Aflibercept for central retinal vein occlusions: long-term outcomes of a ‘Treat-and-Extend’ regimen
The T&E regimen for CRVO shows sustained visual improvements and reduced CST over time. Patients maintained stable visual gains for many years, demonstrating the effectiveness of this treatment approach. However, no control group was available to compare our T&E regimen with other strategies.
Authors
- Sebastián Wolf
- Florian M. Heussen (ORCID: https://orcid.org/0000-0003-0536-9870)
- Martin Sebastian Zinkernagel (ORCID: https://orcid.org/0000-0003-3447-2359)
- Damian Jaggi (ORCID: https://orcid.org/0000-0002-3670-6983)
- Thanoosha Nagamany
Institutions
- University Hospital of Bern (CH)
Publication Details
- Journal
- BMJ Open Ophthalmology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/bmjophth-2024-001659
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08